It is a life sciences public limited company based in Pune, Maharashtra, India, established in 2005.
2005 | Pune, Maharashtra, India | ActiveIatro Pharma And Biotech Limited, a active public limited company, was established on 15 July 2005 in Pune, Maharashtra, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U24232PN2005PLC021025. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹4.58 Cr.
It upholds a compliant status. Its leadership includes Ajit Ratilal Shah (Director), Sharad Babulal Shah (Director), Anilkumar Ratilal Shah (Director). Past directors included Rajesh Pesuram Wadhwa, Ajit Ratilal Shah, Sharad Babulal Shah. It holds no open charges and ₹6.00 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Sonigra Chambers Market Yard Road Gultekdi, Pune, Maharashtra, 411037.
U24232PN2005PLC021025
021025
15 July 2005
₹7.00 Cr
₹4.58 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Iatro Pharma And Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajit Ratilal Shah | Director | 31 Mar 2019 | Current |
| Sharad Babulal Shah | Director | 30 Mar 2010 | Current |
| Anilkumar Ratilal Shah | Director | 30 Mar 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Jun 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 05 Mar 2010 | Past |
| Pramod Abcsdd | Director | 05 Apr 2010 | Past |
| Pramod Abcsdd | Director | 30 Mar 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Mar 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Iatro Pharma And Biotech Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2019, Iatro Pharma And Biotech had a promoter holding of 8.48% and a public holding of 91.52%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹60,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2006 | Bank Of India | ₹6.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Iatro Pharma And Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Iatro Pharma And Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iatro Pharma And Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Iatro Pharma And Biotech Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Progress on Iatro Pharma And Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune. was documented.
The activity Ajit Ratilal Shah was appointed as a Director was appointed as a Director on 31 Mar 2019 & has been associated with this company since 6 years 8 months . was completed.
Progress on A charge registered on 01 Nov 2006 via Charge ID 10024591 with Bank Of India was fully satisfied on 29 May 2014. was documented.
The activity Sharad Babulal Shah was appointed as a Director was appointed as a Director on 30 Mar 2010 & has been associated with this company since 15 years 8 months . was completed.
The activity Anilkumar Ratilal Shah was appointed as a Director was appointed as a Director on 30 Mar 2010 & has been associated with this company since 15 years 8 months . was completed.
The CIN of Iatro Pharma And Biotech Limited is U24232PN2005PLC021025.
Iatro Pharma And Biotech Limited is headquartered at Sonigra Chambers Market Yard Road Gultekdi, Pune, Maharashtra, 411037.
Iatro Pharma And Biotech Limited was incorporated on 15 July 2005.
The current directors of Iatro Pharma And Biotech Limited are
The primary industry of Iatro Pharma And Biotech Limited is Life Sciences.
Iatro Pharma And Biotech Limited is unlisted.
The authorized capital of Iatro Pharma And Biotech Limited is ₹7.00 Cr, and the paid-up capital is ₹4.58 Cr.
The compliance status of Iatro Pharma And Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX